Norway· NO-ID_FEBB60BA-99A1-4EF3-95EC-694FED9346E0

Cedur retard

A bezafibrate product containing bezafibrate, registered in Norway by Puren. The same ATC class is registered in 10 of our 19 countries.

ATC C10AB02

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedCedur retardATCC10AB02REGISTER NO.NO-ID_FEBB60BA-99A1-4…PACKS LISTED2CHECKEDSeptember 25, 2026

Where it is registered

Bezafibrate is registered in 10 of 19 countries.

Countries holding a registration under ATC C10AB02 (bezafibrate), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 6 of them publish a price we can compare per daily dose

Bezafibrate · ATC C10AB02

10 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Franceprice
  • Germany
  • Italyprice
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of bezafibrate costs, country by country.

Normalised to the WHO defined daily dose (0.6 g), the median price runs from $0.29 in France to $1.19 in Switzerland — a ×4.1 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Bezafibrate · price per daily dose (0.6 g)

USD · FX 28 Sept 2026

  • CH Switzerland$1.19
  • IT Italy$0.44
  • FR France$0.29
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FEST (Norway)
Active substance
Bezafibrate
Manufacturer
Puren
Country
Norway (NO)
ATC code
C10AB02
ATC class
Bezafibrate
Defined daily dose
0.6 g, O
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 2

  • no_merkevare_id
    ID_FEBB60BA-99A1-4EF3-95EC-694FED9346E0
  • no_varenummer
    363918
    100

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Bezafibrate in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bezafibrate products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

  • Austria · Bezalip Retard, Bezastad
  • Belgium · Cedur, Eulitop
  • Cyprus · Lacromid, Zafibral
  • Germany · Bezafibrat Al, Bezafibrat Retard Al
  • Spain · Eulitop, Eulitop Retard
  • Finland · Bezalip
  • France · Befizal, Befizal L.P.
  • United Kingdom (Northern Ireland) · Bezafibrate, Bezafibrate Noumed Life Sciences
  • Hungary · Bezalip
  • Italy · Bezalip
  • Luxembourg · Cedur, Eulitop
  • Netherlands · Bezafibrate Aurobindo
  • Portugal · Bezalip, Bezalip Retard
  • Romania · Bezafibrat Arena
  • Sweden · Bezalip, Bezalip Retard

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c4ee7dc1-7d87-4b0a-a480-aa86ea083067
GET /v1/drugs/c4ee7dc1-7d87-4b0a-a480-aa86ea083067?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Depottablett",
  "source": "fest",
  "status": "A",
  "atc_name": "Bezafibrat",
  "merkevare_id": "ID_FEBB60BA-99A1-4EF3-95EC-694FED9346E0",
  "name_form_strength": "Cedur retard depottab 400 mg",
  "prescription_group": "C"
}

See everything about bezafibrate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.